129 related articles for article (PubMed ID: 15934302)
21. Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy.
Jin H; Piao SG; Jin JZ; Jin YS; Cui ZH; Jin HF; Zheng HL; Li JJ; Jiang YJ; Yang CW; Li C
Nephron Exp Nephrol; 2014; 126(3):148-56. PubMed ID: 24855017
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.
Qian Y; Li S; Ye S; Chen Y; Zhai Z; Chen K; Yang G
J Endocrinol Invest; 2008 Dec; 31(12):1069-74. PubMed ID: 19246972
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
[TBL] [Abstract][Full Text] [Related]
24. Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy.
Suzuki H; Kanno Y; Ikeda N; Nakamoto H; Okada H; Sugahara S
Hypertens Res; 2002 Nov; 25(6):865-73. PubMed ID: 12484510
[TBL] [Abstract][Full Text] [Related]
25. Renal protective effects of blocking the intrarenal renin-angiotensin system.
Li J; Zhou C; Yu L; Wang H
Hypertens Res; 1999 Sep; 22(3):223-8. PubMed ID: 10515446
[TBL] [Abstract][Full Text] [Related]
26. Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression.
Xue L; Feng X; Wang C; Zhang X; Sun W; Yu K
BMC Nephrol; 2017 Oct; 18(1):307. PubMed ID: 28978304
[TBL] [Abstract][Full Text] [Related]
27. [Effect of Chinese herbs for stasis removing and collaterals dredging upon angiotensin-converting enzyme 2-angiotensin-(1-7)-mas axis in the renal cortex of diabetic nephropathy rats].
Xu J; Ma EW; Bai L; Ma Y; Guo Q; Jia R; Zhang JH; Chen ZQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):714-21. PubMed ID: 25046956
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy.
Navale AM; Paranjape A
J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):359-364. PubMed ID: 29617268
[TBL] [Abstract][Full Text] [Related]
29. Effect of benazepril on the transdifferentiation of renal tubular epithelial cells from diabetic rats.
Peng T; Wang J; Zhen J; Hu Z; Yang X
Biomed Rep; 2014 Jul; 2(4):490-494. PubMed ID: 24944793
[TBL] [Abstract][Full Text] [Related]
30. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
[TBL] [Abstract][Full Text] [Related]
31. Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.
Tawfik MK; Keshawy MM; Makary S
Mol Biol Rep; 2021 Sep; 48(9):6457-6470. PubMed ID: 34431038
[TBL] [Abstract][Full Text] [Related]
32. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
[TBL] [Abstract][Full Text] [Related]
33. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
[TBL] [Abstract][Full Text] [Related]
34. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
[TBL] [Abstract][Full Text] [Related]
35. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
Tunçdemir M; Öztürk M
Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
[TBL] [Abstract][Full Text] [Related]
38. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
[TBL] [Abstract][Full Text] [Related]
39. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
[TBL] [Abstract][Full Text] [Related]
40. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism.
Remuzzi A; Fassi A; Sangalli F; Malanchini B; Mohamed EI; Bertani T; Remuzzi G
Exp Nephrol; 1998; 6(1):28-38. PubMed ID: 9523171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
